{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:37:48Z","timestamp":1792291068035,"version":"4.4.0"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Phototherapy is the most commonly used treatment for vitiligo, with initial pigment appearing at the perifollicular site, eventually coalescing into uniform pigmentation due to melanocyte migration from hair follicles. Melanocyte activity is higher during the anagen phase of the hair cycle, which is prolonged by minoxidil.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>To assess if topical minoxidil enhances the rate of pigmentation during phototherapy for the treatment of vitiligo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods:<\/jats:title>\n                    <jats:p>In this double-blinded, randomized control study, the efficacy of minoxidil in inducing repigmentation was compared with the vehicle used as a placebo. Thirty vitiligo patients with a minimum of 2 patches were included and randomized into 2 groups and treated with phototherapy. Minoxidil 5% solution was randomly applied on one patch and vehicle on the other patch. The vitiligo area severity index (VASI) score of the lesion was measured at baseline and then at 4, 8, and 12 weeks for each lesion. Physician and patient global assessment scores were recorded at week 12.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      In minoxidil group, the baseline VASI score of 94 \u00b1 9.68% reduced to 47.76 \u00b1 17.25% at 12 weeks. In the placebo group, the VASI score reduced from 94 \u00b1 9.68% to 67.93 \u00b1 16.88%. Reduction in VASI was found to be greater in minoxidil group as compared with the placebo group (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      value = &lt;0.001). The difference in the physician and patient\u2019s global assessment scores in both minoxidil and placebo groups was also statistically significant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Limitations:<\/jats:title>\n                    <jats:p>The study had a small sample size and a short follow-up period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Concomitant use of phototherapy and minoxidil increases the rate of pigmentation with reduction in VASI score.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/idoj.idoj_1242_24","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T12:00:14Z","timestamp":1755259214000},"page":"21-26","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Phototherapy with Topical Minoxidil in Vitiligo: A Randomized Control Trial"],"prefix":"10.4103","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4502-342X","authenticated-orcid":false,"given":"Sejal","family":"Bajoria","sequence":"first","affiliation":[{"name":"Department of Dermatology, Venereology and Leprosy, Kalinga Institute of Medical Sciences, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9893-5343","authenticated-orcid":false,"given":"Chakravarthi R.","family":"Srinivas","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Leprosy, Kalinga Institute of Medical Sciences, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nithya","family":"Satish","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Consultant Dermatologist, Ranga\u2019s Centre of Dermatology, Coimbatore, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2042-7333","authenticated-orcid":false,"given":"Riya","family":"Sukhija","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Leprosy, Kalinga Institute of Medical Sciences, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6671-6452","authenticated-orcid":false,"given":"Kriti","family":"Jain","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Leprosy, Kalinga Institute of Medical Sciences, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6285-8090","authenticated-orcid":false,"given":"Garima","family":"Manocha","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Leprosy, Kalinga Institute of Medical Sciences, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3624-5178","authenticated-orcid":false,"given":"Laxman","family":"Besra","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Leprosy, Kalinga Institute of Medical Sciences, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"key":"R1-20251229","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1159\/000506103","article-title":"Vitiligo: A review","volume":"236","author":"Bergqvist","year":"2020","journal-title":"Dermatol Basel Switz"},{"key":"R2-20251229","first-page":"1","article-title":"An update on new and emerging options for the treatment of vitiligo","volume":"13","author":"Mahmoud","year":"2008","journal-title":"Skin Ther Lett"},{"key":"R3-20251229","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4103\/idoj.IDOJ_310_18","article-title":"What is new in narrow-band Ultraviolet-B therapy for vitiligo?","volume":"10","author":"Khanna","year":"2019","journal-title":"Indian Dermatol Online J"},{"key":"R4-20251229","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/JD9.0000000000000128","article-title":"Mobilization of melanocytes during NB-UVB treatment of vitiligo","volume":"4","author":"Li","year":"2021","journal-title":"Int J Dermatol Venereol"},{"key":"R5-20251229","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1080\/09546634.2021.1945527","article-title":"Minoxidil: A comprehensive review","volume":"33","author":"Gupta","year":"2022","journal-title":"J Dermatolog Treat"},{"key":"R6-20251229","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-4362.1990.tb04096.x","article-title":"Acceleration of repigmentation in vitiligo by topical minoxidil in patients on photochemotherapy","volume":"29","author":"Srinivas","year":"1990","journal-title":"Int J Dermatol"},{"key":"R7-20251229","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4103\/Pigmentinternational.Pigmentinternational_3_19","article-title":"Enhanced repigmentation of vitiligo by topical minoxidil and excimer lamp treatment","volume":"6","author":"Kanellis","year":"2019","journal-title":"Pigment Int"},{"key":"R8-20251229","doi-asserted-by":"crossref","first-page":"4910","DOI":"10.3390\/ijms24054910","article-title":"Vitiligo, from pathogenesis to therapeutic advances: State of the art","volume":"24","author":"Diotallevi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R9-20251229","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4103\/0378-6323.48662","article-title":"Evaluation of narrow-band UVB phototherapy in 150 patients with vitiligo","volume":"75","author":"Kumar","year":"2009","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R10-20251229","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/j.1365-4632.2011.05454.x","article-title":"Systemic PUVA vs. narrowband UVB in the treatment of vitiligo: A randomized controlled study","volume":"51","author":"Sapam","year":"2012","journal-title":"Int J Dermatol"},{"key":"R11-20251229","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.2147\/DDDT.S214907","article-title":"Minoxidil and its use in hair disorders: A review","volume":"13","author":"Suchonwanit","year":"2019","journal-title":"Drug Des Devel Ther"},{"key":"R12-20251229","doi-asserted-by":"crossref","first-page":"231","DOI":"10.17656\/jsmc.10365","article-title":"Efficacy of topical minoxidil 5% and betamethasone valerate 0.1% versus betamethasone valerate 0.1% monotherapy in non-segmental vitiligo","volume":"12","author":"Ali","year":"2022","journal-title":"J Sulaimani Med College"},{"key":"R13-20251229","doi-asserted-by":"crossref","first-page":"6438","DOI":"10.1038\/s41598-023-32591-8","article-title":"The efficacy of bimatoprost ophthalmic solution combined with NB-UVB phototherapy in non-segmental and segmental vitiligo: A single-blind randomized controlled study","volume":"13","author":"Silpa-Archa","year":"2023","journal-title":"Sci Rep"}],"container-title":["Indian Dermatology Online Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/idoj.idoj_1242_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:42:16Z","timestamp":1787067736000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/idoj.idoj_1242_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/idoj.idoj_1242_24","relation":{},"ISSN":["2229-5178","2249-5673"],"issn-type":[{"value":"2229-5178","type":"print"},{"value":"2249-5673","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,14]]},"assertion":[{"value":"2024-12-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}